Apellis Pharmaceuticals (APLS) Return on Assets (ROA)
Market Cap: $2.18B
Avg Volume: 1.97M
Industry: Biotechnology
Sector: Healthcare
Apellis Pharmaceuticals Return on Assets (ROA) Summary
Apellis Pharmaceuticals's ROA indicates the return generated on the company's assets:
- Annual: -22.36%
- Quarterly: -4.11%
- TTM: -22.36%
What is Return on Assets (ROA)?
Return on Assets (ROA) is a financial ratio that shows the percentage of profit a company earns in relation to its overall resources. It is an indicator of how efficiently a company is using its assets to generate earnings.
Related Metrics
Other important metrics to assess Apellis Pharmaceuticals's profitability include:
- ROE (Return on Equity) - measures the return generated on shareholders' equity:
- Annual: -86.58%
- Quarterly: -15.91%
- TTM: -79.42%
- ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
- Annual: -33.35%
- Quarterly: -3.73%
- TTM: -23.50%
- Return on Tangible Assets - measures the return generated on the company's tangible assets:
- Annual: -22.36%
- Quarterly: -4.11%
- TTM: -22.36%
- Profit Margin - shows the percentage of revenue that has turned into profit:
- Annual: -27.87%
- Quarterly: -17.11%
- TTM: -25.32%
These metrics provide insights into Apellis Pharmaceuticals's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual ROA
-22.36%
Quarterly ROA
-4.11%
TTM ROA
-22.36%
Apellis Pharmaceuticals Historical ROA
Historical ROE
Historical ROIC
Historical Profit Margin
Historical Return on Tangible Assets
Apellis Pharmaceuticals Historical Profitability Metrics
The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | ROA | ROE | ROIC | Profit Margin | Return on Tangible Assets |
|---|---|---|---|---|---|
| 2024 | -22.36% | -86.58% | -33.35% | -27.87% | -22.36% |
| 2023 | -67.02% | -271.76% | -94.82% | -133.29% | -67.02% |
| 2022 | -85.79% | -383.92% | -99.50% | -864.70% | -85.79% |
| 2021 | -84.64% | -375.69% | -71.15% | -1121.27% | -84.64% |
| 2020 | -35.90% | -168.60% | -25.71% | -137.59% | -35.90% |
| 2019 | -79.59% | -905.11% | -89.09% | 0.00% | -79.59% |
| 2018 | -62.64% | -79.21% | -67.70% | 0.00% | -62.64% |
| 2017 | -28.01% | -34.25% | -29.06% | 0.00% | -28.01% |
| 2016 | -98.88% | -114.00% | 0.67% | 0.00% | -98.88% |
| 2015 | -121.84% | -132.99% | -57.19% | 0.00% | -121.84% |
Related Metrics
Explore detailed financial metrics and analysis for APLS.